Europe — EMA
Ophel (Opipramol Hydrochloride)
GNH USA supplies Ophel (Opipramol Hydrochloride), a tricyclic antidepressant for anxiety, somatoform and depressive disorders. Request a quote for supply.
Request sourcing
What is Opipramol Hydrochloride?
Opipramol Hydrochloride, the active ingredient in Ophel, is a tricyclic antidepressant presented as a tablet for oral use. It treats generalized anxiety disorder, somatoform disorders, and depressive disorders in adult patients.
GNH USA supplies Ophel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Opipramol Hydrochloride used for?
Opipramol Hydrochloride is employed in the management of anxiety‑related and depressive conditions.
- Generalized anxiety disorder: reduces anxiety symptoms and improves overall functioning. - Somatoform disorders: alleviates somatic symptom burden and associated distress. - Depressive disorders: improves mood and lessens depressive symptoms.
What are the side effects of Opipramol Hydrochloride?
Adverse reactions may occur with Ophel use.
Common Side Effects: - Drowsiness - Dry mouth - Constipation - Dizziness - Weight gain - Blurred vision
Serious or Rare Side Effects: - Cardiac arrhythmia or QT prolongation - Severe hypotension - Hepatic dysfunction - Blood dyscrasias such as agranulocytosis - Seizures - Suicidal ideation or behavior
What precautions apply to Opipramol Hydrochloride?
Before initiating therapy, consider the following safety measures.
- Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown; weigh potential risks against benefits. - Elderly patients: start with a low dose and monitor for excessive sedation. - Concomitant CNS depressants: may increase sedation and respiratory depression. - Discontinuation: avoid abrupt cessation to reduce withdrawal risk. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.
What does Opipramol Hydrochloride interact with?
Ophel may interact with several medicines; awareness of the interaction level is essential.
Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension or serotonin syndrome. - CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation and respiratory depression. - Anticholinergic drugs: additive anticholinergic effects.
Moderate Interactions (Monitor Closely): - Serotonergic agents (SSRIs, SNRIs): potential for serotonin syndrome. - Antihistamines: increased drowsiness. - Cardiac drugs (e.g., quinidine): possible QT interval prolongation.



